Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, BFA

Transaction Data Systems Partners with Community Pharmacies to Fight the Opioid Epidemic with Release of NarcFacts


OCOEE, Fla., Oct. 15, 2018 /PRNewswire/ -- Transaction Data Systems, Inc., the leader in pharmacy management software including Rx30 and Computer-Rx, is helping community pharmacies fight controlled substance abuse with integrated tools to streamline PDMP review.

"The launch of NarcFacts brings an innovative solution to a nationwide epidemic. Community pharmacy is uniquely positioned to impact substance abuse through daily patient engagement. Our pharmacy management platforms now help pharmacies facilitate change within the care continuum," Jude Dieterman, TDS President and CEO. "It's tools like these, which integrate PDMP review into the pharmacy's workflow, that are going to help community pharmacies make a big impact on the opioid epidemic."

Using the NarcFacts integration, pharmacies are alerted to overlapping pharmacies and prescribers, high doses, duplications or other potential problems directly through their pharmacy management platform. From the alert screen, they can learn more about warnings, access multi-state PDMP data records, and view an interactive prescribing graph and geomap of dispensing history.

"NarcFacts is an innovative solution designed to integrate seamlessly with the pharmacy management software to become part of the pharmacy's daily prescription filling process," explains Jeff Pohler, TDS Clinical Services vice president. "If there is a potential problem, the pharmacy is alerted through their pharmacy management system, saving time and effort while ensuring compliance."

NarcFacts is an exclusive solution available to community pharmacies only through Computer-Rx and Rx30 platforms. NarcFacts gives nearly half of all community pharmacies the opportunity to remain compliant with their state's reporting requirements without leaving their pharmacy management platform, and, most importantly, the ability to impact lives of patients affected by the opioid epidemic. Visit www.NarcFacts.com to learn more. 

About Transaction Data Systems (TDS)

For more than four decades, TDS has been dedicated to the success of community pharmacy. TDS, through its family of products including Rx30, Computer-Rx and Enhanced Medication Services, provides pharmacy management systems and other innovative technology to the pharmacy industry. Its proven software solutions and continually growing, evolving products and services offer pharmacies the technology and support they need to succeed. Proudly supporting the largest install base of community pharmacies in the industry with systems in all 50 states, TDS is the unquestioned leader in community pharmacy management software.

 

 

TDS logo with brands

SOURCE Transaction Data Systems


These press releases may also interest you

at 03:05
VIAVI Solutions ("VIAVI") notes the announcement made by Keysight Technologies, Inc. ("Keysight") and Spirent Communications plc ("Spirent") on March 28, 2024, of a recommended cash acquisition of Spirent by Keysight. VIAVI believes that its...

at 03:04
Policybazaar, India's leading online insurance marketplace, is witnessing a significant increase in non-resident Indians (NRIs) choosing term insurance from India via its platform. This surge is driven by the unparalleled ease, affordability and...

at 03:00
TRON Forum (Chair: Ken Sakamura, Professor Emeritus of the University of Tokyo) is pleased to announce that four microcontroller manufacturers, Infineon Technologies Japan K.K. (President & CEO: Ikuya Kawasaki), STMicroelectronics K.K. (Country...

at 02:00
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for March 29, 2024. OKX...

at 00:30
Frost & Sullivan recently researched the data center colocation services industry and, based on its findings, recognizes STT GDC India with the 2023 Indian Company of the Year Award. STT GDC India is a pioneer data center solutions provider that...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: